Vagal nerve block for weight loss in pancreatic cancer
Part of Cancer clinical trials.
This trial tests a device that blocks signals from the vagus nerve to see if it can help stop or reverse weight loss (cachexia) in people with metastatic pancreatic cancer who have already lost at least 5% of their body weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that has spread to other parts of your body (metastatic).
- You have lost at least 5% of your body weight since your diagnosis.
- Your cancer got worse after at least one previous treatment for advanced disease.
- You are about to start or are already on another line of cancer treatment.
- You don't have certain heart or neck conditions or implants that would make the device unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a non-invasive device that uses low-level radio waves to standard chemotherapy (gemcitabine and nab-paclitaxel) can help people with pancreatic cancer that has spread to other parts of the body.
This trial tests a wearable device that gently stimulates a nerve in your neck to reduce extreme tiredness caused by immune-boosting cancer treatments. You'll wear it for 4 weeks while continuing your cancer medicine, and researchers will see if it helps you feel less fatigued.
This Phase 2 trial tests whether a device that delivers carefully timed “radiofrequency heat” through the body can slow or control metastatic (spread) pancreatic cancer. You may qualify if you have newly diagnosed metastatic pancreatic cancer and can meet safety and blood-test requirements.
This trial tests a new form of a drug (nano-megestrol acetate) to help people with advanced pancreatic cancer who are losing weight and have poor appetite. It aims to see if it can improve cachexia, a condition of severe weight loss and muscle wasting.
This trial tests whether an early nerve block during endoscopy can better control pain from pancreatic cancer compared to waiting and using standard treatments.
This trial tests if a nerve block can help control pain after gastric bypass or sleeve gastrectomy. The goal is to reduce the need for strong pain medicines and improve recovery.
Hear when a new Metastatic Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.